Tata Chemicals Q1 FY27 profit drops to Rs 60 crore

Key takeaway from the June-quarter print

Tata Chemicals Limited reported a sharp year-on-year drop in consolidated profitability for the quarter ended 30 June 2026 (Q1 FY27). Consolidated net profit for the quarter came in at Rs 60 crore, compared with Rs 316 crore in Q1 FY26. The company also disclosed higher consolidated expenses for the quarter and updated segment-wise revenue numbers for its Living Essentials and Industrial Essentials businesses. Alongside the results, market data showed the stock trading lower by a little over 2% on both the BSE and NSE in the latest update carried in the information shared.

Consolidated profit falls year-on-year

For Q1 FY27, Tata Chemicals reported consolidated net profit of Rs 60 crore. In the corresponding quarter last year (Q1 FY26), consolidated net profit was Rs 316 crore. The company also reported consolidated basic and diluted earnings per share (EPS) for the quarter at Rs (0.67). While the dataset includes multiple historical references to earlier quarters and prior-year performance, the headline change for this June-quarter update is the large gap between Q1 FY27 and Q1 FY26 net profit.

Revenue, total income, and what the company reported

On the consolidated basis, revenue from operations for Q1 FY27 was Rs 4,255 crore, compared with Rs 3,719 crore in Q1 FY26. Total consolidated income for the quarter was reported at Rs 4,311 crore, compared with Rs 3,815 crore in the year-ago period. These are the figures provided for the two comparable quarters. The same information set also carries a separate “Quarterly - Tata Chemicals Q1 Results” table where “Total Revenue” for “Jun 25” is shown as Rs 3,719 crore, which aligns with the Q1 FY26 revenue from operations figure cited above.

Expense build-up: materials and employee costs

Tata Chemicals reported total consolidated expenses of Rs 4,184 crore in Q1 FY27, compared with Rs 3,497 crore in Q1 FY26. Within the expense mix for Q1 FY27, cost of materials consumed was Rs 887 crore and employee benefits expense was Rs 545 crore. The expense line items help explain the cost structure during the quarter, even as the company’s consolidated profit for the period was materially lower than the prior-year quarter.

Segment snapshot: Living Essentials and Industrial Essentials

The company disclosed segment revenues for the quarter. The Living Essentials segment reported revenue of Rs 1,064 crore in Q1 FY27. Industrial Essentials contributed Rs 2,240 crore during Q1 FY27. These segment numbers offer a quick view of how Tata Chemicals’ key operating buckets performed on the revenue line in the June quarter.

Standalone performance: profit and revenue edge higher

On a standalone basis, Tata Chemicals reported profit for the period of Rs 343 crore for Q1 FY27, up from Rs 307 crore in Q1 FY26. Standalone revenue from operations was Rs 1,281 crore in Q1 FY27, compared with Rs 1,169 crore in the previous year’s corresponding quarter. The standalone trend in the information provided differs from the consolidated picture, with standalone profit rising year-on-year even as consolidated net profit is reported sharply lower.

Other comprehensive income and EPS disclosure

The company reported consolidated other comprehensive income (OCI) gain or loss for Q1 FY27 at Rs 887 crore, compared with Rs 721 crore in Q1 FY26. Separately, consolidated basic and diluted EPS for the quarter was reported at Rs (0.67). These disclosures sit alongside the profit and loss numbers and are relevant for investors tracking the total comprehensive income movement and per-share metrics.

Stock reaction and price levels mentioned

The information set shows Tata Chemicals shares trading lower on both exchanges at the time of the update. On the BSE, the stock was at Rs 729.35, down Rs 16.90 or 2.26%, with volume of 44.10 K. On the NSE, it was at Rs 729.65, down Rs 16.55 or 2.22%, with volume of 6.74 L. The data also lists the day’s price band as Rs 726.50 to Rs 746.25, and a 52-week range of Rs 581.30 to Rs 1,026.00.

Corporate actions and governance updates around FY26

Tata Chemicals concluded its 87th Annual General Meeting on June 26, 2026. Shareholders approved adoption of the audited standalone and consolidated financial statements for FY26 and declared a dividend on ordinary shares for the year ended March 31, 2026. The members re-appointed Mr. S. Padmanabhan (DIN: 00306299) as Director for a term up to and inclusive of May 14, 2028, and ratified the remuneration of the cost auditors. Separately, Tata Chemicals had announced June 10, 2026 as the record date for the Rs 11 per share dividend recommended for FY26, with documentation submission deadline stated as June 8, 2026.

Trading window closure noted ahead of results

The company also disclosed a trading window closure effective June 24, 2026 in connection with the declaration of financial results for the quarter ending June 30, 2026. The closure was stated to be pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the Tata Code of Conduct. The trading window was to reopen 48 hours after the results are declared to the stock exchanges, and the date for the Board meeting to approve the results was to be communicated separately.

Summary table: Q1 FY27 vs Q1 FY26 and market snapshot

Why this update matters for investors

The June-quarter disclosure puts the spotlight on the divergence between consolidated and standalone performance for Tata Chemicals. Consolidated net profit for Q1 FY27 is reported far lower than the year-ago quarter, while standalone profit and standalone revenue from operations are higher year-on-year. Investors also track expense trends, particularly total consolidated expenses, materials consumed, and employee benefits, as these can influence operating outcomes across cycles. The segment revenue disclosure for Living Essentials and Industrial Essentials adds another layer for understanding where reported revenues are coming from within the broader business.

Conclusion

Tata Chemicals’ Q1 FY27 numbers, as presented, show consolidated net profit of Rs 60 crore against Rs 316 crore a year ago, with consolidated revenue from operations at Rs 4,255 crore and expenses at Rs 4,184 crore. The stock was indicated lower by a little over 2% on both BSE and NSE in the cited market update. Separately, the company’s FY26 shareholder actions, including the Rs 11 per share dividend and the June 10, 2026 record date, along with the trading window closure framework around results, outline the key corporate events investors typically track alongside quarterly earnings.